NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,197 filers reported holding NOVARTIS A G in Q3 2023. The put-call ratio across all filers is 1.00 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $9,066 | +0.9% | 89 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $8,981 | +306.7% | 89 | +270.8% | 0.00% | +200.0% |
| Q1 2023 | $2,208 | +1.4% | 24 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $2,177 | -99.9% | 24 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $1,824,000 | -10.1% | 24 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $2,029,000 | -9.8% | 24 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $2,250,000 | +7.2% | 24 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $2,099,000 | +6.9% | 24 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $1,963,000 | -4.3% | 24 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $2,052,000 | -9.4% | 24 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $2,266,000 | +8.6% | 24 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $2,087,000 | -0.4% | 24 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $2,096,000 | +104700.0% | 24 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $2,000 | 0.0% | 24 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $2,000 | 0.0% | 24 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $2,000 | – | 24 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GODSEY & GIBB, INC | 184,900 | $15,121,000 | 6.74% |
| Martin Investment Management, LLC | 289,924 | $23,710,000 | 5.98% |
| Camber Capital Management LP | 2,000,000 | $163,560,000 | 5.04% |
| MANAGED ASSET PORTFOLIOS, LLC | 381,778 | $31,222,000 | 4.76% |
| PROFESSIONAL ADVISORY SERVICES INC | 267,779 | $21,899,000 | 3.22% |
| SCHARF INVESTMENTS, LLC | 1,244,711 | $101,794,000 | 3.21% |
| GARLAND CAPITAL MANAGEMENT INC | 50,755 | $4,151,000 | 2.97% |
| First Fiduciary Investment Counsel, Inc. | 167,378 | $13,688,000 | 2.67% |
| WILKINS INVESTMENT COUNSEL INC | 130,590 | $10,680,000 | 2.61% |
| Lowell Blake & Associates Inc. | 66,309 | $5,423,000 | 2.52% |